Table 1 Baseline characteristics of participants.
Characteristics | All (N = 37) |
|---|---|
Median age, year, median (range) | 62 (27, 78) |
Age, year, n (%) | |
≤60 | 16 (43.2) |
>60 | 21 (56.8) |
Sex, n (%) | |
Male | 18 (48.6) |
Female | 19 (51.4) |
Pathological types, n (%) | |
Non-GCB DLBCL | 25 (67.6) |
GCB DLBCL | 12 (32.4) |
Double-expressor lymphomasa, n (%) | |
Yes | 12 (32.4) |
No | 25 (67.6) |
Ki67, %, median (range) | 80 (60, 95) |
Multiple lesions, n (%) | |
Yes | 23 (62.2) |
No | 14 (37.8) |
Deep brain lesionsb, n (%) | |
Yes | 27 (73) |
No | 10 (27) |
Concurrent sites, n (%) | |
Leptomeningeal | 2 (5.4) |
Spinal cord | 1 (2.7) |
Intra-ocular | 1 (2.7) |
Lactate dehydrogenase, n (%) | |
Elevated | 6 (16.2) |
Normal | 31 (83.8) |
CSF Protein, n (%) | |
Elevated | 13 (35.1) |
Normal | 24 (64.9) |
ECOG PS, n (%) | |
1 | 14 (37.8) |
2 | 21 (56.8) |
3 | 2 (5.4) |
IELSG scoring system, n (%) | |
Low risk | 6 (16.2) |
Intermediate risk | 27 (73) |
High risk | 4 (10.8) |
MSKCC scoring system, n (%) | |
Low risk | 5 (13.5) |
Intermediate risk | 16 (43.2) |
High risk | 16 (43.2) |
Diagnosis modality, n (%) | |
Stereotactic/open biopsy of intracranial lesions | 14 (37.8) |
Maximal safe resection of intracranial lesions | 23 (62.2) |
